Publications

Evaluation of recent literature to untangle the respective roles of lipopolysaccharide and (1→3)-β-D-Glucan as biomarkers of HIV progression and immune activation on antiretroviral therapy

Assessing the contribution of fungal polysaccharide (1→3)-β-D-Glucan (βDG) to systemic immune activation in people living with HIV

Studying cannabis use and mental health symptoms among men who have sex with men

Examination of rates of resistance to tenofovir or emtricitabine among antiretrociral-naive patients in clinical care

Studying the effect of ART initiation time on HIV-1 DNA reservoir in chronically infected individuals

Studying the key topics contemplated at the CAHR and CFID collaborated workshop targeted to mid-career virology researchers

Examination of the longitudinal dynamics of leukocyte telomere length during pregnancy amongst women living with HIV

The first large, randomized, CCTA-based assessment of the effects of a primary prevention strategy for CVD on high-risk CAD, immune activation and inflammation among people living with HIV

The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) is a prospective, randomized, placebo-controlled trial of a statin strategy for the primary prevention of major adverse cardiovascular events in people living with HIV with low to moderate traditional risk

Studying how NK cell education status infleunces Ab-dependent cellular cytotoxicity levels